Safety issues in cell-based intervention trials
- 1 November 2003
- journal article
- review article
- Published by Elsevier in Fertility and Sterility
- Vol. 80 (5) , 1077-1085
- https://doi.org/10.1016/s0015-0282(03)02218-0
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Transplanted bone marrow regenerates liver by cell fusionNature, 2003
- Cell fusion is the principal source of bone-marrow-derived hepatocytesNature, 2003
- RAC Hears a Plea for Resuming Trials, Despite Cancer RiskScience, 2003
- Adenovirus E1a protein enhances the cytotoxic effects of the herpes thymidine kinase-ganciclovir systemCancer Gene Therapy, 2003
- Second cancer case halts gene-therapy trialsNature, 2003
- Policy developments in regulatory approvalStatistics in Medicine, 2002
- Suicide gene transduction sensitizes murine embryonic and human mesenchymal stem cells to ablation on demand – a fail-safe protection against cellular misbehaviorGene Therapy, 2002
- Positive Effect of Transplantation of hNT Neurons (NTera 2/D1 Cell-Line) in a Model of Familial Amyotrophic Lateral SclerosisExperimental Neurology, 2002
- Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 DiseaseScience, 2000
- Proliferative Responses to Human Immunodeficiency Virus Type 1 (HIV‐1) gp120 Peptides in HIV‐1–Infected Individuals Immunized with HIV‐1 rgp120 or rgp160 Compared with Nonimmunized and Uninfected ControlsThe Journal of Infectious Diseases, 1999